Polycythaemia Flashcards
Define polycythaemia
Increase in haemoglobin concentration above the upper limit normal to age and sex
What are the types of polycythaemia
Relative (lack of plasma)/ pseudopolycythaemia: alcohol, obesity, diuretics
True:
Primary (myeloproliferative neoplasm): philadelphia Chr -ve or +ve
Secondary (non-malignant)
What are the causes of true primary polycythaemia
Primary (myeloproliferative neoplasm): suppressed EPO
Philadelphia Chr -ve:
- essential thrombocythaemia (megakaryocyte)
- Polycythaemia vera (erythroid)
- Primary myelofibrosis
Philadelphia chromosome +ve:
CML
What are the causes of secondary true polcythaemia
Raised EPO
Appropriate (JAK2 wild type/V617F/Exon12):
- High altitude
- Hypoxic lung disease (COPD)
- Cyanotic heart disease
- High affinity Hb
Inappropriate:
- Renal disease (cysts, tumours, inflammation)
- Uterine myoma
- Other tumours (liver, lung)
Epidemiology of polycythaemia
Median age of diagnosis is 61
M > F in PV
Thrombosis and thrombocytosis were more frequent in women
Symptoms of polycythaemia
Asymptomatic
Symptoms caused by hyperviscosity:
- Headache
- Dizziness
- Dyspnoea
- Tinnitus
- Blurred vision
- Fatigue
- Night sweats
Symptoms of histamine release
- Pruritus after hot bath
- Peptic ulceration
Thrombosis symptoms: Calf swelling, calf pain, sudden onset SOB and chest pain
Signs of polycythaemia on examination
General
- Plethoric complexion
- Scratch marks due to itching
- Conjunctival suffusion
- Retinal venous engorgement
Obs
- Hypertension
Abdominal
- Splenomegaly (75% of polycythaemia rubra vera)
Investigations for polycythaemia
Sats: ? secondary poly
FBC:
- Raised Hb/Hct/red cell mass
- Reduced MCV
- PV → raised WCC/platelets
CRP/ESR
U&Es: raised urate
vit B12: raised in myeloproliferative
Erythropoietin:
- PV: reduced
- Secondary: raised
JAK2 mutation screening: +ve in PV
Isotope dilution techniques: raised cell mass (distinguish between relative and absolute)
Bone marrow biopsy: hypercellular/raised megakaryocytes/erythroid hyperplasia
Cytogenetics: differentiate from CML
CT abdo/brain: ?EPO-secreting tumours
Management for polycythaemia vera
Venesection (only suitable in younger/healthy patients)
Cytoreductive therapy: less DNA synthesis in RBCs
1. Hydroxycarbamide
- Keep plts <400 x 109/L
- Keep Hct <45%
2. Interferon, Jak-2 inhibitors e.g. ruxolitinib
3. Busulfan
Aspirin 75mg daily
Gout → allopurinol
Pruritus → anti-histamines, SSRIs, interferon
Management for secondary polycythaemia
Correct the underlying cause
Reduce HCT <55%
Complications of polycythaemia
Myelofibrosis (30%)
Acute myeloid leukaemia (5%)
Cardiovascular: thrombosis, haemorrhage
Prognosis for polycythaemia vera
Life expectancy of patients with PV is reported to be modestly reduced compared with that of the general population
Median overall survival is 15 years